Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A Cash Flow Reinvestment Rate
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A cash flow reinvestment rate. Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A (002864) has a Cash Flow Reinvestment Rate of 0.64x as of September 2025, reinvesting CN¥17.01 Million (capex CN¥17.01 Million ) from operating cash flow of CN¥26.54 Million. See Shaanxi Panlong Pharmaceutical Group Lim (002864) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A (2013–2025)
Cash flow reinvestment rate of Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A from 2013 to 2025. Historical reinvestment intensity for Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A across 13 annual periods. Explore 002864 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A Cash Flow Reinvestment Rate by Year (2013–2025)
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A cash flow reinvestment rate by year from 2013 to 2025. Year-by-year capital reinvestment analysis for Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A. For the full cash flow conversion analysis, see Shaanxi Panlong Pharmaceutical Group Lim operating cash flow efficiency.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.67x | CN¥42.41 Million | CN¥63.01 Million | CN¥42.41 Million | ▲ +25.4% |
| 2024 | 0.54x | CN¥84.05 Million | CN¥156.59 Million | CN¥82.05 Million | ▼ -55.3% |
| 2023 | 1.20x | CN¥124.92 Million | CN¥104.05 Million | CN¥62.51 Million | ▲ +128.6% |
| 2022 | 0.53x | CN¥65.84 Million | CN¥125.36 Million | CN¥55.84 Million | ▼ -32.8% |
| 2021 | 0.78x | CN¥90.68 Million | CN¥116.04 Million | CN¥80.68 Million | ▼ -76.4% |
| 2020 | 3.31x | CN¥305.18 Million | CN¥92.24 Million | CN¥71.18 Million | ▲ +498.2% |
| 2019 | 0.55x | CN¥37.55 Million | CN¥67.89 Million | CN¥33.55 Million | ▼ -89.6% |
| 2018 | 5.34x | CN¥250.06 Million | CN¥46.85 Million | CN¥20.06 Million | ▼ -40.1% |
| 2017 | 8.91x | CN¥253.45 Million | CN¥28.45 Million | CN¥23.45 Million | ▲ +1907.0% |
| 2016 | 0.44x | CN¥27.52 Million | CN¥61.99 Million | CN¥17.06 Million | ▼ -60.0% |
| 2015 | 1.11x | CN¥45.08 Million | CN¥40.62 Million | CN¥45.08 Million | ▲ +66.2% |
| 2014 | 0.67x | CN¥32.42 Million | CN¥48.56 Million | CN¥32.42 Million | ▼ -44.4% |
| 2013 | 1.20x | CN¥30.55 Million | CN¥25.43 Million | CN¥30.55 Million | — |